Viktor V Feketa1, Yi Zhang, Zhijuan Cao, Adithya Balasubramanian, Christopher M Flores, Mark R Player, Sean P Marrelli. 1. 1Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, TX. 2Department of Anesthesiology, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, Hubei, China. 3Department of Anesthesiology, Baylor College of Medicine, Houston, TX. 4Drug Discovery, Janssen Research & Development, LLC, Spring House, PA.
Abstract
OBJECTIVES: Mild decrease in core temperature (therapeutic hypothermia) provides lasting neuroprotection following cardiac arrest or cerebral ischemia. However, current methods for producing therapeutic hypothermia trigger a cold-defense response that must be countered by sedatives, muscle paralytics, and mechanical ventilation. We aimed to determine methods for producing hypothermia in the conscious mouse by targeting two transient receptor potential channels involved in thermoregulation, two transient receptor potential (TRP) channels involved in thermoregulation, TRP vanilloid 1 (TRPV1) and TRP melastatin 8 (TRPM8). DESIGN: Controlled prospective animal study. SETTING: Research laboratory at academic medical center. SUBJECTS: Conscious unrestrained young and aged male mice. INTERVENTIONS: Mice were treated with the TRPV1 agonist dihydrocapsaicin, a TRPM8 inhibitor ("compound 5"), or their combination and the effects on core temperature (Tcore) were measured by implanted thermocouples and wireless transponders. MEASUREMENTS AND MAIN RESULTS: TRPV1 agonist dihydrocapsaicin produced a dose-dependent (2-4 mg/kg s.c.) drop in Tcore. A loading dose followed by continuous infusion of dihydrocapsaicin produced a rapid and prolonged (> 6 hr) drop of Tcore within the therapeutic range (32-34°C). The hypothermic effect of dihydrocapsaicin was augmented in aged mice and was not desensitized with repeated administration. TRPM8 inhibitor "compound 5" (20 mg/kg s.c.) augmented the drop in core temperature during cold exposure (8°C). When "compound 5" (30 mg/kg) was combined with dihydrocapsaicin (1.25-2.5 mg/kg), the drop in Tcore was amplified and prolonged. CONCLUSIONS: Activating warm receptors (TRPV1) produced rapid and lasting hypothermia in young and old mice. Furthermore, hypothermia induced by TRPV1 agonists was potentiated and prolonged by simultaneous inhibition of TRPM8.
OBJECTIVES: Mild decrease in core temperature (therapeutic hypothermia) provides lasting neuroprotection following cardiac arrest or cerebral ischemia. However, current methods for producing therapeutic hypothermia trigger a cold-defense response that must be countered by sedatives, muscle paralytics, and mechanical ventilation. We aimed to determine methods for producing hypothermia in the conscious mouse by targeting two transient receptor potential channels involved in thermoregulation, two transient receptor potential (TRP) channels involved in thermoregulation, TRP vanilloid 1 (TRPV1) and TRP melastatin 8 (TRPM8). DESIGN: Controlled prospective animal study. SETTING: Research laboratory at academic medical center. SUBJECTS: Conscious unrestrained young and aged male mice. INTERVENTIONS:Mice were treated with the TRPV1 agonist dihydrocapsaicin, a TRPM8 inhibitor ("compound 5"), or their combination and the effects on core temperature (Tcore) were measured by implanted thermocouples and wireless transponders. MEASUREMENTS AND MAIN RESULTS:TRPV1 agonist dihydrocapsaicin produced a dose-dependent (2-4 mg/kg s.c.) drop in Tcore. A loading dose followed by continuous infusion of dihydrocapsaicin produced a rapid and prolonged (> 6 hr) drop of Tcore within the therapeutic range (32-34°C). The hypothermic effect of dihydrocapsaicin was augmented in aged mice and was not desensitized with repeated administration. TRPM8 inhibitor "compound 5" (20 mg/kg s.c.) augmented the drop in core temperature during cold exposure (8°C). When "compound 5" (30 mg/kg) was combined with dihydrocapsaicin (1.25-2.5 mg/kg), the drop in Tcore was amplified and prolonged. CONCLUSIONS: Activating warm receptors (TRPV1) produced rapid and lasting hypothermia in young and old mice. Furthermore, hypothermia induced by TRPV1 agonists was potentiated and prolonged by simultaneous inhibition of TRPM8.
Authors: J P Nolan; P T Morley; T L Vanden Hoek; R W Hickey; W G J Kloeck; J Billi; B W Böttiger; P T Morley; J P Nolan; K Okada; C Reyes; M Shuster; P A Steen; M H Weil; V Wenzel; R W Hickey; P Carli; T L Vanden Hoek; D Atkins Journal: Circulation Date: 2003-07-08 Impact factor: 29.690
Authors: Andras Garami; Eszter Pakai; Daniela L Oliveira; Alexandre A Steiner; Samuel P Wanner; M Camila Almeida; Vladimir A Lesnikov; Narender R Gavva; Andrej A Romanovsky Journal: J Neurosci Date: 2011-02-02 Impact factor: 6.167
Authors: Kees H Polderman; Rudi Tjong Tjin Joe; Saskia M Peerdeman; William P Vandertop; Armand R J Girbes Journal: Intensive Care Med Date: 2002-10-04 Impact factor: 17.440
Authors: Viktor V Feketa; Adithya Balasubramanian; Christopher M Flores; Mark R Player; Sean P Marrelli Journal: Am J Physiol Regul Integr Comp Physiol Date: 2013-09-04 Impact factor: 3.619
Authors: H Bart van der Worp; Emily S Sena; Geoffrey A Donnan; David W Howells; Malcolm R Macleod Journal: Brain Date: 2007-05-03 Impact factor: 13.501
Authors: Andrej A Romanovsky; Maria C Almeida; Andras Garami; Alexandre A Steiner; Mark H Norman; Shaun F Morrison; Kazuhiro Nakamura; Jeffrey J Burmeister; Tatiane B Nucci Journal: Pharmacol Rev Date: 2009-09-11 Impact factor: 25.468
Authors: Keld Fosgerau; Uno J Weber; Jacob W Gotfredsen; Magdalena Jayatissa; Carsten Buus; Niels B Kristensen; Mogens Vestergaard; Peter Teschendorf; Andreas Schneider; Philip Hansen; Jakob Raunsø; Lars Køber; Christian Torp-Pedersen; Charlotte Videbaek Journal: BMC Cardiovasc Disord Date: 2010-10-09 Impact factor: 2.298
Authors: Ashley A Krull; Sarah A Larsen; Donald K Clifton; Genevieve Neal-Perry; Robert A Steiner Journal: Endocrinology Date: 2017-10-01 Impact factor: 4.736
Authors: Isaac R Bailey; Bernard Laughlin; Lucille A Moore; Lori K Bogren; Zeinab Barati; Kelly L Drew Journal: J Pharmacol Exp Ther Date: 2017-06-26 Impact factor: 4.030
Authors: Sung-Ha Hong; Jeong-Ho Hong; Matthew T Lahey; Liang Zhu; Jessica M Stephenson; Sean P Marrelli Journal: J Neurosci Methods Date: 2021-05-28 Impact factor: 2.987
Authors: Zhijuan Cao; Adithya Balasubramanian; Steen E Pedersen; Jonathan Romero; Robia G Pautler; Sean P Marrelli Journal: Sci Rep Date: 2017-12-15 Impact factor: 4.379